Implication of Perivascular Adipose Tissue as a Potential Therapeutic Target for the Vascular Defensive Actions of Incretin-Based Therapies and SGLT2 Inhibitors
This review explores the potential mechanisms by which incretin-based therapies and SGLT2 inhibitors provide cardiovascular protection. The authors identify perivascular adipose tissue (PVAT) as a key regulator of vascular tone and inflammation. While these therapies offer cardiovascular benefits beyond glucose lowering, the precise mechanisms remain unclear. This review proposes PVAT and its signaling as novel therapeutic targets to explain how these treatments provide vascular protection.
What to check after reading
This review proposes perivascular adipose tissue as a novel therapeutic target for incretin-based therapies and SGLT2 inhibitors, offering a new perspective on their vascular protective effects.
Source
Calendar dates show when a case was added or scheduled. For event dates, check the original source.